Wash U Spinout PerianDX Raises $30M
St. Louis-based PierianDx has been able to raise $30 million in financing. Launched in 2014, PierianDx was spun out of Washington University.
PierianDx's software and services provide clinical genomic analysis for treatment of complex diseases.
New York-based health care investment firm OrbiMed, Health Catalyst Capital, Research Triangle Institute, Inova Health System, ATW Partners and SJF Ventures have invested in PierianDx.